Showing 2001-2010 of 7005 results for "".
Everest ER: Practicing Medicine at 17,000 Feet
https://reachmd.com/programs/clinicians-roundtable/everest-er-practicing-medicine-17000-feet/9692/Dr. Luanne Freer talks about the perils and triumphs of founding and operating a clinic at 17,000 feet.Hyperpigmentation in Darker Skin Types: A Review of Current Treatments
https://reachmd.com/programs/practical-dermatology/hyperpigmentation-in-darker-skin-types-a-review-of-current-treatments/24217/Pigmentary disorders are a leading concern for patients and consumers worldwide.Monitoring Disease Course and Treatment Response in Various Populations With Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/monitoring-disease-course-and-treatment-response-in-various-populations-with-multiple-sclerosis/33144/Monitoring for signs of disease activity or progression in multiple sclerosis—a crucial component of disease management—may need refinement for pediatric, pregnant or postpartum, older, and minority or underserved populations.The History of Quarantine
https://reachmd.com/programs/covid-19-frontlines/the-history-of-quarantine/11419/Quarantines have been used all over the world amid our battle against COVID-19, but they’ve also been used in medicine for close to two centuries.Autologous Hair Follicle-Derived Secretomes
https://reachmd.com/ma-issues-index/may-jun-2026-issue/autologous-hair-follicle-derived-secretomes/57933/A regenerative, cell-free therapy can enhance follicular function, improve scalp health, and expand non-surgical treatment options for androgenetic alopecia.Rapidly Progressive Dementia and Plateau Waves: A Rare Presentation of Leptomeningeal Disease
https://reachmd.com/programs/practical-neurology/rapidly-progressive-dementia-and-plateau-waves-a-rare-presentation-of-leptomeningeal-disease/33145/The authors present a rare clinical marker in a patient with rapidly progressive dementia which can aid appropriate diagnostic evaluation.First-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
https://reachmd.com/programs/clinicians-roundtable/first-in-human-trial-of-a-germline-targeting-hiv-env-trimer-vaccine/32855/Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
https://reachmd.com/programs/cme/advancing-bispecific-antibodies-upstream-in-the-treatment-paradigm-of-multiple-myeloma/49263/Review emerging evidence supporting earlier use of bispecific antibodies in multiple myeloma, with a focus on efficacy, safety, and optimizing patient outcomes.Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
https://reachmd.com/programs/cme/transforming-care-in-pediatric-patients-with-c3-glomerulopathy-targeting-c3-at-the-source/54143/Join Drs. Daga and Lafayette for a case discussion exploring the optimal use of complement inhibitor therapy in a pediatric patient with C3 glomerulopathy.CGM in the Real T2D World
https://reachmd.com/programs/cme/cgm-real-t2d-world/50982/Continuous glucose monitoring (CGM) is still recommended for all individuals with diabetes, including those with type 2 diabetes (T2D). Despite this, its use in managing T2D has not been as widespread as expected. New evidence has recently highlighted the benefits of CGM for people with T2D. Join ou